DASANAT 50MG

What is DASANAT 50MG?

DASANAT 50MG is a tyrosine kinase inhibitor (TKI) that contains Dasatinib 50 mg as its active ingredient. It is an oral anticancer medicine used primarily in the treatment of chronic myeloid leukemia (CML) and some forms of acute lymphoblastic leukemia (ALL).

What is the use of DASANAT 50MG?

• Treatment of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML) in adults and children.

• Used for Ph+ acute lymphoblastic leukemia (ALL) in patients resistant or intolerant to previous therapies.

• Helps prevent disease progression and improves survival rates in leukemia patients.

Benefits of DASANAT 50MG:

• Targets cancer cells specifically by inhibiting BCR-ABL tyrosine kinase activity.

• Reduces proliferation of abnormal white blood cells in leukemia.

• Can be used in patients resistant or intolerant to other leukemia treatments.

• Oral tablet formulation allows convenient home administration.

• Improves quality of life and long-term disease management in leukemia patients.

Side Effects of DASANAT 50MG:

Common side effects:

• Nausea, vomiting, diarrhea

• Headache, fatigue, dizziness

• Muscle or joint pain

• Swelling in hands, feet, or around the eyes

• Low blood cell counts (anemia, neutropenia, thrombocytopenia)

Serious side effects (require immediate medical attention):

• Bleeding or bruising easily

• Shortness of breath or fluid accumulation in lungs (pleural effusion)

• Severe infections due to low immunity

• Liver function abnormalities

• Allergic reactions (rash, swelling, difficulty breathing)